No definition available.
Disorders of male genital organs in diseases classified elsewhere
EFO MESH Endpoint Browser PheWeb
N14_MALEGENINOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly males |
226754 |
2. Check conditionsNone |
226754 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
235 |
4. Check minimum number of eventsNone |
235 |
5. Include endpointsNone |
235 |
6. Filter based on genotype QC (FinnGen only) |
226 |
Control definitions (FinnGen only)
- Control exclude
- N14_MALEGEN
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of male genital organs in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Diseases of male genital organs
- Genitourinary diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2125 | - | 2125 |
| Only index persons | 2038 | - | 2038 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | - | 0.06 |
| Only index persons | 0.08 | - | 0.08 |
| Median age at first event (years) | |||
| Whole population | - | - | 34.45 |
| Only index persons | - | - | 34.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 226 | - | 226 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 47.05 | - | 47.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 235
- Matched controls
- 2350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N51.8*A60.0
ICD-10 Finland
Herpes simplex infection of the genitals in men
606.6
112.7
103
*
N51.2*B37.4
ICD-10 Finland
Candidal balanitis
331.9
53.5
52
*
N48.1
ICD-10 Finland
Balanoposthitis
18.9
48.9
41
26
J05AB11
ATC
valaciclovir; oral
7.4
40.9
74
138
N51.2
ICD-10 Finland
Balanitis in diseases classified elsewhere
204.5
34.8
35
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
7.2
31.2
53
91
J05AB01
ATC
aciclovir; systemic
5.5
30.2
75
185
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
7.9
23.1
34
49
N51.8
ICD-10 Finland
Other disorders of male genital organs in diseases classified elsewhere
+∞
22.2
21
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
4.0
22.1
86
294
J02AC01
ATC
fluconazole; systemic
4.1
20.0
71
226
KGH10
NOMESCO Finland
Operation for phimosis
+∞
17.9
17
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
21.3
17.3
25
13
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
24.1
17.2
24
11
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
43.5
16.6
20
5
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.6
15.5
41
103
N40
ICD-10 Finland
Hyperplasia of prostate
3.6
15.0
59
198
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.5
14.0
60
212
UKC02
NOMESCO Finland
Cystoscopy
4.2
13.4
40
110
J01MA02
ATC
ciprofloxacin; systemic
2.8
12.7
99
489
G04CB01
ATC
finasteride; oral
4.1
12.6
38
105
XKD00
NOMESCO Finland
Uroflowmetry
3.8
11.7
40
121
N03AF01
ATC
carbamazepine; oral, rectal
5.8
11.1
21
39
G04CA01
ATC
alfuzosin; oral
3.1
10.6
53
204
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.2
9.9
43
152
N41.1
ICD-10 Finland
Chronic prostatitis
9.7
9.7
19
21
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
9.7
118
699
N02BF01
ATC
gabapentin; oral
4.4
9.5
25
62
N02AX02
ATC
tramadol; systemic, rectal
2.4
9.4
111
646
A63.0
ICD-10 Finland
Anogenital (venereal) warts
5.4
9.3
19
38
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.9
8.9
48
192
J01MA01
ATC
ofloxacin; systemic
4.3
8.8
24
61
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.3
8.8
24
61
N03AX12
ATC
[U] gabapentin; oral
3.0
8.8
45
174
N51.1
ICD-10 Finland
Disorders of testis and epididymis in diseases classified elsewhere
52.0
8.7
10
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
9.5
8.7
17
19
N03AX16
ATC
[U] pregabalin
2.6
8.5
58
261
N48.8
ICD-10 Finland
Other specified disorders of penis
93.3
8.5
9
*
G04CA02
ATC
tamsulosin; oral
2.4
8.4
74
375
J01DA01
ATC
[U] cefalexin
2.2
7.6
140
953
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
8.1
7.5
16
21
D07AC01
ATC
betamethasone; topical
2.2
7.5
87
493
L17
ICPC
Foot/toe symptom/complaint
2.4
7.5
61
298
K30
ICD-10 Finland
Functional dyspepsia
3.5
7.4
27
85
J02AC02
ATC
itraconazole; systemic
2.9
7.3
38
148
UJF30
NOMESCO Finland
Ileoscopy through colon
3.3
7.2
28
92
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
7.1
114
729
J01DB01
ATC
cefalexin; oral
2.5
6.9
194
1535
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
6.8
68
360
R12
ICD-10 Finland
Heartburn
3.8
6.8
21
59
K08.80
ICD-10 Finland
Toothache NOS
3.6
6.7
23
69
KED22
NOMESCO Finland
Transurethral resection of prostate
23.3
6.7
9
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
6.6
83
481
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
6.6
32
120
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.2
6.5
26
87
G04CB02
ATC
dutasteride; oral
3.4
6.4
24
77
Y04
ICPC
Penis symptom/complaint other
11.5
6.4
11
10
N03AE01
ATC
clonazepam; systemic
3.9
6.3
19
52
M03BX02
ATC
tizanidine; oral
2.0
6.3
141
1003
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
6.3
25
83
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
+∞
6.3
6
*
KGB00
NOMESCO Finland
Biopsy of penis
+∞
6.3
6
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
6.2
76
435
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.4
6.2
23
73
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
6.2
113
748
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
6.1
56
286
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
69
189
4.75
24.07
2.1
2.2
—
—
—
0
0
72
211
4.48
22.95
2.1
2.3
—
—
—
0
0
21
14
16.33
13.37
1.2
1.4
—
—
—
0
0
46
172
3.08
9.59
4.6
3.8
30.33
28.40
%
0.46
30
122
178
1304
2.50
8.48
9.4
8.3
73.92
79.18
u/l
0.69
171
1244
166
1191
2.34
8.11
5.1
3.8
10.22
11.07
mm/h
0.24
153
1104
217
1782
3.84
7.88
17.3
13.3
21.01
26.06
mg/l
1.46
181
1403
120
784
2.08
7.07
12.1
12.6
1.29
1.27
inr
0.06
32
224
109
690
2.08
6.96
7.4
5.3
37.04
36.27
g/l
0.68
103
648
129
869
2.07
6.96
6.7
7.4
10.79
12.78
umol/l
2.86
124
841
21
59
3.81
6.76
1.6
3.0
—
—
—
0
0
114
751
2.01
6.37
10.2
8.6
1.21
1.20
mmol/l
0.52
102
655
19
55
3.67
5.87
1.5
2.8
—
—
—
0
0
103
682
1.91
5.44
9.0
7.9
1.20
1.20
mmol/l
0.03
95
636
10
11
9.43
5.34
1.1
1.0
—
—
—
0
0
20
69
3.08
4.73
4.2
3.4
—
—
—
0
0
98
662
1.82
4.70
4.2
3.3
28.50
59.34
ng/l
1.82
69
444
133
985
1.81
4.69
6.4
6.0
6.97
6.93
mmol/l
0.07
127
942
179
1470
1.91
4.33
4.6
3.5
1.81
1.95
mu/l
1.08
161
1353
101
707
1.75
4.18
2.7
2.6
—
—
—
0
0
80
525
1.79
4.12
2.3
2.3
69.44
72.55
nmol/l
0.42
68
479
141
1087
1.74
4.12
5.6
3.7
8.75
1.62
ug/l
0.59
129
970
81
534
1.79
4.11
3.4
3.1
—
—
—
0
0
102
724
1.72
3.97
2.9
2.7
0.00
0.00
estimate
-0.00
11
104
56
336
1.88
3.82
3.0
3.8
1859.67
766.21
ng/l
0.28
42
268
209
1838
2.24
3.80
19.6
15.8
4.02
4.02
mmol/l
0.15
204
1789
51
300
1.89
3.69
2.3
2.3
13.52
14.48
nmol/l
0.37
42
276
100
719
1.68
3.64
4.0
3.9
0.00
0.00
estimate
—
10
113
6
6
10.22
3.51
1.0
1.0
—
—
—
0
0
226
2104
2.94
3.29
25.4
18.8
42.31
42.25
%
0.06
206
1969
98
716
1.63
3.27
2.8
2.8
0.00
0.01
estimate
0.50
12
115
125
970
1.62
3.26
11.7
10.5
3.99
4.13
e9/l
0.32
115
850
75
514
1.67
3.20
4.3
2.9
57.17
65.81
u/l
0.46
70
487
76
523
1.67
3.19
5.2
4.0
5.31
8.37
mg/mmol
0.57
49
363
54
338
1.78
3.18
1.9
2.0
0.78
1.47
mg/l
1.89
41
253
220
2006
2.52
3.16
13.2
9.7
31.69
33.69
u/l
0.90
214
1952
226
2108
2.88
3.15
25.4
18.5
4.73
4.76
e12/l
0.36
220
2043
10
26
3.97
3.01
1.1
1.1
—
—
—
0
0
11
32
3.55
2.94
1.4
1.2
—
—
—
0
0
64
431
1.67
2.89
3.3
3.5
1399.21
1252.51
ng/l
0.08
54
362
67
458
1.65
2.85
4.8
3.6
2.33
2.34
mmol/l
0.28
59
412
58
383
1.68
2.81
2.3
2.5
—
—
—
0
0
5
6
8.48
2.76
1.6
1.0
—
—
—
0
0
5
6
8.48
2.76
1.6
1.0
—
—
—
0
0
5
6
8.48
2.76
1.6
1.0
—
—
—
0
0
47
296
1.73
2.70
1.6
1.4
—
—
—
0
0
42
258
1.76
2.62
1.7
1.9
—
—
—
0
0
6
11
5.56
2.56
1.0
1.2
—
—
—
0
0
13
51
2.64
2.49
2.1
1.6
—
—
—
0
0
6
12
5.10
2.41
1.3
2.1
945.67
821.33
u/ml
—
6
12
5
8
6.36
2.38
1.4
1.3
—
—
—
0
0
136
1128
1.49
2.32
3.5
2.9
14.96
14.76
pmol/l
0.40
122
1027
29
166
1.85
2.28
4.0
3.9
1.43
1.62
mmol/l
0.10
22
139
34
205
1.77
2.27
1.4
1.2
1.51
11.25
u/ml
—
10
89
11
41
2.76
2.24
1.8
2.7
—
768.00
—
0
5
78
582
1.51
2.22
2.1
1.8
94.34
89.97
pmol/l
0.33
34
346
145
1225
1.48
2.21
3.4
2.9
—
—
—
0
0
29
169
1.82
2.16
5.0
7.6
—
—
—
0
0
76
567
1.50
2.16
3.0
2.8
—
—
—
0
0
190
1714
1.57
1.97
13.4
12.1
86.54
86.19
ml/min/173m2
0.07
159
1429
7
22
3.25
1.89
1.1
1.0
—
—
—
0
0
84
658
1.43
1.82
4.7
3.9
30.40
37.74
u/l
1.68
77
620
186
1681
1.51
1.80
7.1
5.3
41.19
39.85
mmol/mol
1.08
165
1585
63
470
1.47
1.76
3.1
2.7
333.89
7083.99
umol/l
1.84
54
423
104
851
1.40
1.74
4.9
3.3
19.28
22.71
%
1.52
48
314
6
19
3.21
1.67
1.2
1.1
—
—
—
0
0
74
575
1.42
1.65
3.0
2.4
220.32
210.48
ug/l
0.07
66
536
12
56
2.20
1.64
2.1
1.9
—
—
—
0
0
10
43
2.38
1.61
1.4
1.2
—
—
—
0
0
6
20
3.05
1.59
1.2
1.1
—
—
—
0
0
159
1410
1.39
1.58
4.7
3.2
43.54
53.92
u/l
2.25
151
1349
15
78
1.99
1.58
7.1
11.2
1.78
1.79
%
0.02
15
70
33
219
1.59
1.57
1.4
1.2
9.92
40.36
iu/ml
—
8
71
5
15
3.38
1.53
1.2
1.0
—
—
—
0
0
7
27
2.64
1.52
1.6
1.1
—
—
—
0
0
13
65
2.06
1.52
2.2
1.5
0.13
0.07
iu/ml
—
5
14
6
21
2.90
1.51
1.2
1.5
—
—
—
0
0
6
21
2.90
1.51
1.2
1.5
—
—
—
0
0
6
21
2.90
1.51
1.2
1.5
—
—
—
0
0
6
21
2.90
1.51
1.2
1.5
—
—
—
0
0
6
22
2.77
1.44
1.2
1.5
—
—
—
0
0
6
22
2.77
1.44
1.2
1.5
—
—
—
0
0
9
40
2.30
1.41
3.0
2.0
—
—
—
0
0
26
168
1.62
1.39
11.4
9.3
9.59
9.89
mmol/l
0.09
26
159
44
321
1.46
1.37
1.3
1.2
0.85
1.19
u/ml
0.48
11
93
36
252
1.51
1.37
2.8
2.7
0.29
0.44
e6/l
0.40
21
138
5
17
2.98
1.36
1.0
1.1
—
—
—
0
0
30
203
1.55
1.33
9.9
12.8
1.79
0.90
mmol/l
1.29
25
160
13
69
1.94
1.31
2.5
2.1
0.52
1.25
ug/l
0.45
13
61
34
238
1.50
1.30
1.8
1.6
960.63
1017.25
nmol/l
0.17
22
190
17
100
1.75
1.27
1.5
1.7
—
—
—
0
0
8
37
2.20
1.22
2.3
2.3
24.38
25.19
mmol/l
—
8
37
5
19
2.67
1.22
2.0
1.9
—
—
—
0
0
36
260
1.45
1.19
2.7
2.6
0.57
0.71
e6/l
0.18
22
145
15
87
1.77
1.18
1.8
2.3
39.85
40.73
u/l
0.05
15
76
5
20
2.53
1.15
1.2
2.1
—
—
—
0
0
5
21
2.41
1.09
1.2
2.1
—
—
—
0
0
202
1906
1.43
1.09
5.2
4.4
2.85
2.83
mmol/l
0.10
183
1784
9
46
1.99
1.05
1.3
1.3
—
—
—
0
0
5
22
2.30
1.04
1.2
1.4
—
—
—
0
0
7
34
2.09
1.03
1.0
1.2
—
—
—
0
0
199
1877
1.39
1.03
4.7
4.1
4.67
4.60
mmol/l
0.40
183
1768
46
357
1.36
1.02
3.4
2.9
0.00
0.01
estimate
0.50
11
99
27
190
1.48
1.02
1.6
1.9
—
—
—
0
0
19
124
1.58
1.00
1.8
1.5
—
—
—
0
0
51
404
1.34
1.00
3.1
3.0
0.13
0.41
e6/l
2.06
39
301
5
23
2.20
0.98
2.4
2.9
107.20
105.96
mmol/l
—
5
23
198
1871
1.37
0.97
4.8
4.0
1.26
1.28
mmol/l
0.40
178
1749
24
167
1.49
0.96
9.5
10.0
1.32
1.40
mmol/l
0.24
24
161
9
51
1.79
0.95
1.1
1.0
—
5.51
—
0
7
38
291
1.36
0.92
1.7
1.7
259375364.31
392.62
pmol/l
0.49
32
255
26
188
1.43
0.87
1.6
1.9
—
—
—
0
0
6
30
2.03
0.87
1.0
1.2
—
—
—
0
0
43
343
1.31
0.81
2.2
2.0
2.84
3.15
mg/l
0.35
31
303
12
74
1.66
0.80
1.3
1.5
1.40
1.60
g/l
0.50
12
66
6
33
1.84
0.79
1.0
1.2
179.37
193.03
pmol/l
—
6
33
53
437
1.27
0.78
1.8
1.6
1.62
1.51
mmol/l
0.41
47
368
14
92
1.55
0.74
2.9
2.5
0.64
0.62
%
0.07
14
92
5
25
2.02
0.73
1.0
1.0
—
—
—
0
0
191
1818
1.27
0.71
4.3
3.7
1.55
1.41
mmol/l
1.37
173
1703
12
78
1.57
0.67
1.0
1.1
—
—
—
0
0
7
44
1.61
0.65
1.9
1.2
—
—
—
0
0
7
44
1.61
0.65
1.6
1.7
—
—
—
0
0
21
156
1.38
0.63
2.1
2.3
10.70
11.54
ug/l
0.06
15
144
11
71
1.58
0.63
1.1
1.3
365.56
86.85
iu/ml
—
5
27
17
122
1.42
0.62
4.3
2.8
77.29
65.55
ml/min/173m2
—
7
49
183
1746
1.22
0.58
5.3
4.1
6.23
6.05
mmol/l
0.71
162
1611
23
177
1.33
0.57
11.9
14.2
129.57
124.95
g/l
0.40
23
169
70
623
1.18
0.50
3.1
2.3
0.58
0.69
ug/l
1.14
45
337
7
45
1.57
0.49
1.4
1.5
—
—
—
0
0
7
46
1.54
0.48
1.3
2.0
—
—
—
0
0
14
102
1.40
0.48
1.6
1.6
—
—
—
0
0
39
331
1.21
0.47
1.6
1.5
17.93
18.67
nmol/l
0.10
33
291
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
5
33
1.53
0.41
1.4
1.2
—
—
—
0
0
5
33
1.53
0.41
1.4
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
5
34
1.48
0.40
1.6
1.9
—
—
—
0
0
5
34
1.48
0.40
1.2
2.1
—
—
—
0
0
5
34
1.48
0.40
1.2
2.1
—
—
—
0
0
29
244
1.22
0.38
3.9
3.1
2.43
2.43
mmol/l
0.03
24
214
17
213
0.78
0.38
1.8
1.8
—
—
—
0
0
6
42
1.44
0.36
1.0
1.1
—
—
—
0
0
6
42
1.44
0.36
4.2
6.7
23.72
38.85
mg/l
—
6
37
6
44
1.37
0.34
1.3
1.1
—
—
—
0
0
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
6
46
1.31
0.33
1.3
2.0
—
—
—
0
0
7
52
1.36
0.31
4.0
4.5
—
—
—
0
0
11
84
1.32
0.30
1.3
1.4
—
—
—
0
0
12
98
1.24
0.21
15.1
12.6
26.47
24.74
mmol/l
1.00
12
98
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
8
72
1.11
0.16
1.9
1.2
—
—
—
0
0
24
217
1.12
0.15
3.5
2.5
28.29
24.14
%
0.39
18
198
12
105
1.15
0.11
1.3
1.5
—
—
—
0
0
5
47
1.07
0.09
2.6
1.9
—
—
—
0
0
31
294
1.06
0.07
2.7
2.5
30.21
30.38
s
0.05
31
286
16
166
0.96
0.00
3.2
3.0
—
—
—
0
0
5
58
0.86
0.00
1.6
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
110.26
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
53.64
—
0
9
0
5
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_MALEGENINOTH and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_MALEGENINOTH | 1.305 [1.07, 1.59] | 0.008 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 156 out of 1765 males with N14_MALEGENINOTH died.
Mortality risk
Mortality risk for people of age
years, who have N14_MALEGENINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.236% |
| 5 | No data | 1.558% |
| 10 | No data | 3.758% |
| 15 | No data | 7.027% |
| 20 | No data | 11.796% |
Relationships between endpoints
↥Index endpoint: N14_MALEGENINOTH – Disorders of male genital organs in diseases classified elsewhere
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data